Cargando…
Plasma Kallikrein Cleaved H-kininogen: An End-Point Marker for Contact Activation in vitro and ex vivo
OBJECTIVES: The contact system consists of coagulation factor XII (FXII), prekallikrein, and H-kininogen (HK) and plays important roles in many diseases. Plasma kallikrein (PKa) cleaved HK (cHK) is a marker of contact activation. Presently, we developed a specific and precise enzyme-linked immunosor...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163357/ https://www.ncbi.nlm.nih.gov/pubmed/35669477 http://dx.doi.org/10.3389/fcvm.2022.873975 |
_version_ | 1784719901271785472 |
---|---|
author | Palarasah, Yaseelan Pham, Stephanie Thuy Duong Gram, Jørgen Brodersen Graversen, Jonas Heilskov Pilely, Katrine Sidelmann, Johannes Jakobsen |
author_facet | Palarasah, Yaseelan Pham, Stephanie Thuy Duong Gram, Jørgen Brodersen Graversen, Jonas Heilskov Pilely, Katrine Sidelmann, Johannes Jakobsen |
author_sort | Palarasah, Yaseelan |
collection | PubMed |
description | OBJECTIVES: The contact system consists of coagulation factor XII (FXII), prekallikrein, and H-kininogen (HK) and plays important roles in many diseases. Plasma kallikrein (PKa) cleaved HK (cHK) is a marker of contact activation. Presently, we developed a specific and precise enzyme-linked immunosorbent assay (ELISA) for determination of cHK in vitro and ex vivo. METHODS: Cleaved HK specific mouse monoclonal antibodies (mAbs) were generated using a peptide corresponding to the PKa cleavage site on HK as immunogen. ELISA, surface plasmon resonance analysis, and immunoprecipitation established the specificity of the antibody, which subsequently was used in a sandwich ELISA. The analytical imprecision and the concentration of cHK in a reference population and in women receiving oral contraceptives (OC) were determined. cHK was assessed in vitro in plasma exposed to polytetrafluoroethylene, silicone, and glass tubes. RESULTS: The selected mAb showed excellent specificity towards cHK. The intra-assay and inter-assay CV of the ELISA were 3.6 and 6.0%, respectively. The reference population (60 women, 60 men) displayed a median cHK plasma concentration of 1.38 μg/mL and a reference interval of 0.82 – 2.56 μg/mL. Women receiving OC had significantly higher concentrations, p < 0.001. cHK was significantly elevated in plasma exposed to polytetrafluoroethylene, p = 0.001, and glass, p < 0.0001. CONCLUSION: The ELISA showed excellent precision and specificity. cHK assessment ex vivo demonstrated ongoing contact activation in healthy individuals, augmented by OC. The cHK antibody and the ELISA could be promising tools in contact activation related diseases and in vitro investigations of the plasma compatibility of blood contacting biomaterials. |
format | Online Article Text |
id | pubmed-9163357 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-91633572022-06-05 Plasma Kallikrein Cleaved H-kininogen: An End-Point Marker for Contact Activation in vitro and ex vivo Palarasah, Yaseelan Pham, Stephanie Thuy Duong Gram, Jørgen Brodersen Graversen, Jonas Heilskov Pilely, Katrine Sidelmann, Johannes Jakobsen Front Cardiovasc Med Cardiovascular Medicine OBJECTIVES: The contact system consists of coagulation factor XII (FXII), prekallikrein, and H-kininogen (HK) and plays important roles in many diseases. Plasma kallikrein (PKa) cleaved HK (cHK) is a marker of contact activation. Presently, we developed a specific and precise enzyme-linked immunosorbent assay (ELISA) for determination of cHK in vitro and ex vivo. METHODS: Cleaved HK specific mouse monoclonal antibodies (mAbs) were generated using a peptide corresponding to the PKa cleavage site on HK as immunogen. ELISA, surface plasmon resonance analysis, and immunoprecipitation established the specificity of the antibody, which subsequently was used in a sandwich ELISA. The analytical imprecision and the concentration of cHK in a reference population and in women receiving oral contraceptives (OC) were determined. cHK was assessed in vitro in plasma exposed to polytetrafluoroethylene, silicone, and glass tubes. RESULTS: The selected mAb showed excellent specificity towards cHK. The intra-assay and inter-assay CV of the ELISA were 3.6 and 6.0%, respectively. The reference population (60 women, 60 men) displayed a median cHK plasma concentration of 1.38 μg/mL and a reference interval of 0.82 – 2.56 μg/mL. Women receiving OC had significantly higher concentrations, p < 0.001. cHK was significantly elevated in plasma exposed to polytetrafluoroethylene, p = 0.001, and glass, p < 0.0001. CONCLUSION: The ELISA showed excellent precision and specificity. cHK assessment ex vivo demonstrated ongoing contact activation in healthy individuals, augmented by OC. The cHK antibody and the ELISA could be promising tools in contact activation related diseases and in vitro investigations of the plasma compatibility of blood contacting biomaterials. Frontiers Media S.A. 2022-05-20 /pmc/articles/PMC9163357/ /pubmed/35669477 http://dx.doi.org/10.3389/fcvm.2022.873975 Text en Copyright © 2022 Palarasah, Pham, Gram, Graversen, Pilely and Sidelmann. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Palarasah, Yaseelan Pham, Stephanie Thuy Duong Gram, Jørgen Brodersen Graversen, Jonas Heilskov Pilely, Katrine Sidelmann, Johannes Jakobsen Plasma Kallikrein Cleaved H-kininogen: An End-Point Marker for Contact Activation in vitro and ex vivo |
title | Plasma Kallikrein Cleaved H-kininogen: An End-Point Marker for Contact Activation in vitro and ex vivo |
title_full | Plasma Kallikrein Cleaved H-kininogen: An End-Point Marker for Contact Activation in vitro and ex vivo |
title_fullStr | Plasma Kallikrein Cleaved H-kininogen: An End-Point Marker for Contact Activation in vitro and ex vivo |
title_full_unstemmed | Plasma Kallikrein Cleaved H-kininogen: An End-Point Marker for Contact Activation in vitro and ex vivo |
title_short | Plasma Kallikrein Cleaved H-kininogen: An End-Point Marker for Contact Activation in vitro and ex vivo |
title_sort | plasma kallikrein cleaved h-kininogen: an end-point marker for contact activation in vitro and ex vivo |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163357/ https://www.ncbi.nlm.nih.gov/pubmed/35669477 http://dx.doi.org/10.3389/fcvm.2022.873975 |
work_keys_str_mv | AT palarasahyaseelan plasmakallikreincleavedhkininogenanendpointmarkerforcontactactivationinvitroandexvivo AT phamstephaniethuyduong plasmakallikreincleavedhkininogenanendpointmarkerforcontactactivationinvitroandexvivo AT gramjørgenbrodersen plasmakallikreincleavedhkininogenanendpointmarkerforcontactactivationinvitroandexvivo AT graversenjonasheilskov plasmakallikreincleavedhkininogenanendpointmarkerforcontactactivationinvitroandexvivo AT pilelykatrine plasmakallikreincleavedhkininogenanendpointmarkerforcontactactivationinvitroandexvivo AT sidelmannjohannesjakobsen plasmakallikreincleavedhkininogenanendpointmarkerforcontactactivationinvitroandexvivo |